Privia Health Group (NASDAQ:PRVA) Announces Earnings Results, Beats Expectations By $0.21 EPS

Privia Health Group (NASDAQ:PRVA) issued its quarterly earnings results on Thursday. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21, FiscalAI reports. The firm had revenue of $541.17 million during the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. Privia Health Group’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.21 EPS.

Here are the key takeaways from Privia Health Group’s conference call:

• Strong 2025 financial performance — Privia reported Adjusted EBITDA up 38.8% to $125.5 million, Practice Collections up 16.9% to $3.47 billion, and Care Margin growth of 14.4%, reflecting sizable operating leverage.
• Scale and network growth — Implemented providers rose 12.3% to 5,380 and attributed lives increased 22.7% to 1.54 million; the company also closed the Evolent ACO deal (adding ~120k lives) and entered Arizona with IMS.
• Strong cash generation and balance sheet — Privia converted 130% of EBITDA to free cash flow in 2025, deployed $180 million on transactions, finished 2025 with ~$480 million cash and no debt, and expects ~80% EBITDA-to-FCF conversion and ~ $600 million cash by end-2026 (assumes no new BD).
• 2026 guidance — Management guides to roughly 19.5% Adjusted EBITDA growth to a $150 million midpoint, implemented providers of ~5,950, ~1.58 million attributed lives, Practice Collections growth of ~6.6%, and Care Margin growth of ~13% at the midpoints.
• Key risks and near-term headwinds — Privia will become a full cash taxpayer in 2026 (pressuring FCF conversion versus 2025), and results remain exposed to payer dynamics, shared-savings variability and other forward-looking risks the company highlighted.

Privia Health Group Stock Performance

Privia Health Group stock traded up $2.26 during trading on Thursday, hitting $24.91. The company’s stock had a trading volume of 2,550,543 shares, compared to its average volume of 707,617. The stock’s fifty day moving average is $23.06 and its 200 day moving average is $23.44. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $26.51. The stock has a market capitalization of $3.06 billion, a price-to-earnings ratio of 191.63, a P/E/G ratio of 1.59 and a beta of 0.83.

Key Privia Health Group News

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Reported Q4 and full?year 2025 results topped guidance and street estimates—revenue and EPS beats, adjusted EBITDA and other operating metrics came in at or above the high end of guidance. This is the primary driver of the intraday rally. Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results
• Positive Sentiment: Company issued 2026 guidance above consensus: GAAP revenue guide ~$2.35–$2.45B and ~20% adjusted EBITDA growth at the midpoint, signaling continued top?line and profitability expansion — a clear positive for valuation and analyst sentiment. Privia Health: Q4 Earnings Snapshot
• Positive Sentiment: Strong balance sheet and cash generation: year?end cash ?$480M, no debt, and historic free cash flow conversion — supports growth initiatives and reduces financing risk. Privia Health Group, Inc. Reports Strong 2025 Financial Results
• Neutral Sentiment: Management will host an earnings call/webcast to discuss results and outlook; investors should listen for details on execution, MA risk arrangements and M&A plans that could move the stock further. Privia Health (NASDAQ:PRVA) Reports Strong Q4 CY2025
• Negative Sentiment: Large non?cash stock?based compensation (~$71M in 2025) and other non?GAAP adjustments inflate adjusted metrics; investors should discount some of the headline adjusted figures and watch dilution/comp expense trends. Privia Health beats estimates on earnings and revenue
• Negative Sentiment: Corporate disclosures note management has not reconciled forward?looking non?GAAP measures to GAAP (and there were recent insider share sales flagged in filings), both of which are potential governance/visibility concerns for some investors. Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say

Insider Activity

In other Privia Health Group news, Director Matthew Shawn Morris sold 13,647 shares of Privia Health Group stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $25.01, for a total value of $341,311.47. Following the completion of the sale, the director owned 68,188 shares in the company, valued at $1,705,381.88. The trade was a 16.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO David Mountcastle sold 23,887 shares of the company’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,327,912.27. This represents a 12.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 10.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently bought and sold shares of the stock. Global Retirement Partners LLC boosted its holdings in shares of Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after purchasing an additional 1,351 shares during the last quarter. Canada Pension Plan Investment Board raised its position in shares of Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares during the period. Kestra Advisory Services LLC purchased a new position in shares of Privia Health Group in the 4th quarter worth $93,000. Raymond James Financial Inc. acquired a new position in Privia Health Group in the second quarter valued at $113,000. Finally, Acadian Asset Management LLC purchased a new stake in Privia Health Group during the first quarter valued at about $154,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on PRVA shares. Barclays increased their target price on shares of Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Wolfe Research set a $31.00 price target on Privia Health Group in a report on Tuesday, January 6th. Canaccord Genuity Group lifted their price objective on Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, November 12th. BMO Capital Markets started coverage on Privia Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $30.00 price objective for the company. Finally, Stephens reissued an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a report on Thursday, December 4th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $30.71.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.